Please note, this OEL/ADE monograph also applies to Pyridostigmine bromide (CAS RN 101-26-8), Pyridostigmine hydroxide (CAS RN 587-32-6), Pyridostigmine iodide (CAS RN 4685-03-4), and Pyridostigmine chloride (CAS RN 7681-22-3). Pyridostigmine bromide is used to decrease muscle weakness from myasthenia gravis, treat paralytic ileus and prevent neurotoxicity from Soman, a nerve gas agent. Pyridostigmine bromide inhibits the destruction of acetylcholine by acetylcholine esterase permitting freer transmission of nerve impulses across the neuromuscular junction.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Pyridostigmine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.